摘要
目的 评价非离子型造影剂 (典比乐 370 )在肾动脉介入治疗中的安全性。方法 5 4例冠心病合并肾动脉狭窄患者 (内径减少 >5 0 % )接受肾动脉支架术和冠状动脉介入治疗 (10例单纯肾动脉狭窄患者仅行肾动脉支架术 )与 2 2例冠状动脉及肾动脉均正常者 (对照组 )比较。详细记录术中造影剂用量 ,同时测定患者肾动脉支架术前及术后 12h血清肌酐水平。结果 各组间手术成功率 ,并发症发生率无显著差异。各组间造影剂用量随接受支架植入数升高而增高。术后 12h血清肌酐水平较术前轻微升高 ,但无显著差异。各组间术前肌酐与术后 12h水平比较差异无显著性 (P =0 .0 9)。
Objective To evaluate the safety of non-ionic contras media during interventional treatment of renal artery stenosis (RAS). Methods Fifty four coronary artery disease patients associated with RAS (luminal narrowing>50%) underwent renal artery stent implantation and percutanous coronary intervention, only 10 of them with merely renoarterial stenosis undergone renal artery stent implantation. The successful rates of the procedure and complication together with the volumes of contrast media were recorded respectively. And the serum creatitine before and 12 hours after the successful procedure were also measured. Results Both rates of procedural success and complication were similar among the three groups. The serum creatitine levels, 12 hours after the procedure, showed no difference in comparing with the baseline. Conclusion Non-ionic contrast media (Iopamiro 370) could be safely used in patients with RAS.
出处
《介入放射学杂志》
CSCD
2004年第2期137-139,共3页
Journal of Interventional Radiology
